Industry Sponsorship and Authorship of Clinical Trials Over 20 Years

@article{Buchkowsky2004IndustrySA,
  title={Industry Sponsorship and Authorship of Clinical Trials Over 20 Years},
  author={S. S. Buchkowsky and P. Jewesson},
  journal={Annals of Pharmacotherapy},
  year={2004},
  volume={38},
  pages={579 - 585}
}
  • S. S. Buchkowsky, P. Jewesson
  • Published 2004
  • Medicine
  • Annals of Pharmacotherapy
    • BACKGROUND The pharmaceutical industry has become a major source of funding for biomedical research. Our general observation is that pharmaceutical industry employees are appearing with increasing frequency as coauthors of clinical trial publications. OBJECTIVE To characterize clinical trial funding, reporting, and sources; investigate author—industry affiliation; and describe clinical outcome trends over time. METHODS We reviewed 500 randomly selected clinical trials published in 5 influential… CONTINUE READING
    View on SAGE
    ncbi.nlm.nih.gov
    105 Citations
    Highly Influential Citations
    2
    Background Citations
    24
    Results Citations
    3

    Figures, Tables, and Topics from this paper

    Figures and Tables

    Explore Further: Topics Discussed in This Paper

    105 Citations
    Citation Type

    Citation Type

    Industry sponsorship and research outcome.
    • 365
    • PDF
    Controversies surrounding authorship of manuscripts by industry employees: academic and industry perspectives.
    • Nathaniel R Smilowitz, J. Ferguson, G. Weisz
    • Medicine
    • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
    • 2018
    • PDF
    Relationships between authorship contributions and authors' industry financial ties among oncology clinical trials.
    • 34
    Disclosure of conflicts of interest by authors of clinical trials and editorials in oncology.
    • 57
    Industry-sponsored research.
    • 37
    Association of industry funding with the outcome and quality of randomized controlled trials of drug therapy for rheumatoid arthritis
    • 25
    Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology.
    • 34
    Association of author's financial conflict of interest with characteristics and outcome of rheumatoid arthritis randomized controlled trials.
    • 6
    A cross-sectional analysis of HIV and hepatitis C clinical trials 2007 to 2010: the relationship between industry sponsorship and randomized study design
    • 8
    Questioning a publication bias between industry-funded and non-industry-funded randomized controlled trials on biological and small molecule therapy for rheumatoid arthritis.
    • 1

    References

    SHOWING 1-10 OF 20 REFERENCES
    Pharmaceutical industry sponsorship and research outcome and quality: systematic review
    • 1,802
    • PDF
    Source of funding and outcome of clinical trials
    • R. Davidson
    • Medicine
    • Journal of general internal medicine
    • 1986
    • 259
    Scope and impact of financial conflicts of interest in biomedical research: a systematic review.
    • 1,587
    Managing conflicts of interest in the conduct of clinical trials.
    • 201
    • PDF
    The uncertainty principle and industry-sponsored research
    • 452
    • PDF
    Publication bias and clinical trials.
    • 602
    Funding source, trial outcome and reporting quality: are they related? Results of a pilot study
    • 87
    • PDF
    Bias in reporting clinical trials.
    • A. Bardy
    • Medicine
    • British journal of clinical pharmacology
    • 1998
    • 60
    Pharmaceutical advertising revenue and physician organizations: how much is too much?
    • 40
    Uneasy alliance--clinical investigators and the pharmaceutical industry.
    • 736
    • PDF